Literature DB >> 33861444

Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review.

Atena Mahdavi1, Mohammad Bagherniya1, Mohammad Sadegh Mirenayat2, Stephen L Atkin3, Amirhossein Sahebkar4,5,6,7.   

Abstract

Diabetes is a major health problem affecting more than four hundred million adults worldwide. The transition from normal glucose tolerance to type 2 diabetes (T2D) is preceded by increased Insulin resistance (IR), an independent predictor of the development of T2D in high risk (e.g. obese populations, pre-diabetes) individuals. Insulin deficiency resulting from increased IR results in progressive glucose homeostasis dysfunction. Data has shown that IR is affected by many different factors such as genetics, age, exercise, dietary nutrients, obesity, and body fat distribution. One of the most important factors is diet, which plays an essential role in addressing T2D and metabolic syndrome. Nutraceuticals and medicinal plants have been shown to have efficacy in preventing chronic diseases like cancer, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, diabetes mellitus and metabolic syndrome, likely through the anti-inflammatory properties found in nutraceuticals. However, the effect of these compounds, including traditional plant medicines, herbal formulations or their extracts on IR have not been systematically investigated. The objective of this review was to assess the reported effects of medicinal plants and bioactive natural compounds on IR. The findings confirm that most of the herbal bioactive compounds including resveratrol, garlic, curcumin, cinnamon, ginger, nuts, berberine, anthocyanin, soybean, flaxseed, vegetable oils, and soluble fibers have benefit in their efficacy for decreasing IR, fasting blood sugar (FBS), fasting insulin and HbA1c.

Entities:  

Keywords:  Insulin resistance; Medicinal plants; Metabolic syndrome; Type 2 diabetes

Mesh:

Substances:

Year:  2021        PMID: 33861444     DOI: 10.1007/978-3-030-64872-5_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  128 in total

Review 1.  Type 2 diabetes.

Authors:  Sudesna Chatterjee; Kamlesh Khunti; Melanie J Davies
Journal:  Lancet       Date:  2017-02-10       Impact factor: 79.321

2.  Prevention and screening recommendations in type 2 diabetes: Review and critical appraisal of clinical practice guidelines.

Authors:  Mohammad Diab; Huda A Barhoosh; Balqis Daoudi; Sawsan I AlMukdad; Nancy Ha Zaghloul; Mayar Ashour; Iman A Abdelrahman; Bridget Paravattil; Kyle John Wilby
Journal:  Prim Care Diabetes       Date:  2018-12-12       Impact factor: 2.459

3.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

Review 4.  What causes the insulin resistance underlying obesity?

Authors:  Olga T Hardy; Michael P Czech; Silvia Corvera
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

5.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

6.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

Review 7.  Metabolic dysfunction in diabetic cardiomyopathy.

Authors:  Michael Isfort; Sarah C W Stevens; Stephen Schaffer; Chian Ju Jong; Loren E Wold
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 8.  Structural changes in the myocardium during diabetes-induced cardiomyopathy.

Authors:  Ernest Adeghate; Jaipaul Singh
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 9.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.

Authors:  Guanghong Jia; Vincent G DeMarco; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2015-12-18       Impact factor: 43.330

Review 10.  Diabetes: a 21st century challenge.

Authors:  Paul Z Zimmet; Dianna J Magliano; William H Herman; Jonathan E Shaw
Journal:  Lancet Diabetes Endocrinol       Date:  2013-12-03       Impact factor: 32.069

View more
  4 in total

1.  Protective effect of cinnamon on diabetic cardiomyopathy in nicotinamide-streptozotocin induced diabetic rat model.

Authors:  Chekkilla Uday Kumar; Singareddy Sreenivasa Reddy; Palla Suryanarayana; Madhoosudan A Patil; Periketi Madhusudana Chary; Putcha Uday Kumar; Geereddy Bhanuprakash Reddy
Journal:  J Diabetes Metab Disord       Date:  2022-01-21

2.  Potential for Prebiotic Stabilized Cornus mas L. Lyophilized Extract in the Prophylaxis of Diabetes Mellitus in Streptozotocin Diabetic Rats.

Authors:  Szymon Sip; Daria Szymanowska; Justyna Chanaj-Kaczmarek; Krystyna Skalicka-Woźniak; Barbara Budzyńska; Olga Wronikowska-Denysiuk; Tymoteusz Słowik; Piotr Szulc; Judyta Cielecka-Piontek
Journal:  Antioxidants (Basel)       Date:  2022-02-14

3.  Berberine suppresses advanced glycation end products-associated diabetic retinopathy in hyperglycemic mice.

Authors:  Ning Wang; Leilei Wang; Cheng Zhang; Hor-Yue Tan; Yinjian Zhang; Yibin Feng
Journal:  Clin Transl Med       Date:  2021-11

4.  How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions.

Authors:  Yaseen Hussain; Haroon Khan; Ghallab Alotaibi; Fazlullah Khan; Waqas Alam; Michael Aschner; Philippe Jeandet; Luciano Saso
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.